share_log

Truist Securities Downgrades Axonics to Hold, Lowers Price Target to $71

Benzinga ·  Jan 12 15:29

Truist Securities analyst David Rescott downgrades Axonics (NASDAQ:AXNX) from Buy to Hold and lowers the price target from $73 to $71.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment